(Commission File Number) | (IRS Employer Identification Number) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol | Name of each exchange on which registered |
Exhibit Number | Description | |
99.1 |
AppFolio, Inc. | |||
By: /s/ Ida Kane | |||
Name: Ida Kane | |||
Title: Chief Financial Officer |
Exhibit Number | Description | |
99.1 | Press release issued on March 2, 2020. |
• | Full year revenue is expected to be in the range of $312.0 million to $320.0 million. |
• | Diluted weighted average shares are expected to be approximately 36 million for the full year. |
December 31, 2019 | December 31, 2018 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 15,813 | $ | 74,076 | ||||
Investment securities—current | 22,876 | 16,631 | ||||||
Accounts receivable, net | 7,562 | 5,516 | ||||||
Prepaid expenses and other current assets | 15,540 | 11,775 | ||||||
Total current assets | 61,791 | 107,998 | ||||||
Investment securities—noncurrent | 12,089 | 11,256 | ||||||
Property and equipment, net | 14,744 | 6,871 | ||||||
Operating lease right-of-use assets | 27,803 | — | ||||||
Capitalized software, net | 30,023 | 20,485 | ||||||
Goodwill | 58,425 | 15,548 | ||||||
Intangible assets, net | 21,377 | 5,895 | ||||||
Deferred taxes | 27,574 | — | ||||||
Other long-term assets | 6,276 | 7,688 | ||||||
Total assets | $ | 260,102 | $ | 175,741 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 1,927 | $ | 1,481 | ||||
Accrued employee expenses | 17,758 | 12,377 | ||||||
Accrued expenses | 10,833 | 8,281 | ||||||
Deferred revenue | 4,586 | 3,414 | ||||||
Other current liabilities | 11,139 | 1,447 | ||||||
Long-term debt, net—current portion | 1,208 | 1,213 | ||||||
Total current liabilities | 47,451 | 28,213 | ||||||
Operating lease liabilities | 33,312 | — | ||||||
Long-term debt, net | 47,375 | 48,602 | ||||||
Other long-term liabilities | 14 | 7,080 | ||||||
Total liabilities | 128,152 | 83,895 | ||||||
Stockholders’ equity: | ||||||||
Preferred stock, $0.0001 par value, 25,000 authorized and no shares issued and outstanding at December 31, 2019 and December 31, 2018 | — | — | ||||||
Class A common stock, $0.0001 par value, 250,000 shares authorized at December 31, 2019 and December 31, 2018; issued - 16,923 and 16,160, shares at December 31, 2019 and December 31, 2018, respectively; outstanding - 16,552 and 15,789 shares at December 31, 2019 and December 31, 2018, respectively; | 2 | 2 | ||||||
Class B common stock, $0.0001 par value, 50,000 shares authorized at December 31, 2019 and December 31, 2018; 17,594 and 18,109 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively; | 2 | 2 | ||||||
Additional paid-in capital | 161,509 | 157,898 | ||||||
Accumulated other comprehensive income (loss) | 33 | (178 | ) | |||||
Treasury stock, at cost, 371 Class A shares at December 31, 2019 and December 31, 2018 | (21,562 | ) | (21,562 | ) | ||||
Accumulated deficit | (8,034 | ) | (44,316 | ) | ||||
Total stockholders’ equity | 131,950 | 91,846 | ||||||
Total liabilities and stockholders’ equity | $ | 260,102 | $ | 175,741 |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenue | $ | 67,362 | $ | 50,365 | $ | 256,012 | $ | 190,071 | |||||||
Costs and operating expenses: | |||||||||||||||
Cost of revenue (exclusive of depreciation and amortization) | 26,403 | 19,925 | 101,642 | 73,549 | |||||||||||
Sales and marketing | 14,441 | 9,577 | 51,528 | 33,288 | |||||||||||
Research and product development | 11,086 | 6,588 | 39,508 | 24,111 | |||||||||||
General and administrative | 9,117 | 7,786 | 34,478 | 24,891 | |||||||||||
Depreciation and amortization | 6,226 | 3,792 | 22,395 | 14,576 | |||||||||||
Total costs and operating expenses | 67,273 | 47,668 | 249,551 | 170,415 | |||||||||||
Income from operations | 89 | 2,697 | 6,461 | 19,656 | |||||||||||
Other income (expense), net | 84 | (36 | ) | 16 | (56 | ) | |||||||||
Interest income (expense), net | (330 | ) | 156 | (1,654 | ) | 787 | |||||||||
Income (loss) before provision for (benefit from) income taxes | (157 | ) | 2,817 | 4,823 | 20,387 | ||||||||||
Provision for (benefit from) income taxes | (4,585 | ) | 168 | (31,459 | ) | 420 | |||||||||
Net income | $ | 4,428 | $ | 2,649 | $ | 36,282 | $ | 19,967 | |||||||
Net income per common share: | |||||||||||||||
Basic | $ | 0.13 | $ | 0.08 | $ | 1.07 | $ | 0.59 | |||||||
Diluted | $ | 0.12 | $ | 0.07 | $ | 1.02 | $ | 0.56 | |||||||
Weighted average common shares outstanding: | |||||||||||||||
Basic | 34,091 | 34,050 | 34,016 | 34,128 | |||||||||||
Diluted | 35,597 | 35,425 | 35,567 | 35,562 |
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Costs and operating expenses: | |||||||||||||||
Cost of revenue (exclusive of depreciation and amortization) | $ | 393 | $ | 351 | $ | 1,466 | $ | 1,103 | |||||||
Sales and marketing | 367 | 326 | 1,271 | 1,034 | |||||||||||
Research and product development | 387 | 349 | 1,411 | 1,079 | |||||||||||
General and administrative | 731 | 892 | 3,161 | 3,121 | |||||||||||
Total stock-based compensation expense | $ | 1,878 | $ | 1,918 | $ | 7,309 | $ | 6,337 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) | |||||||||||||||
Three Months Ended December 31, | Twelve Months Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Cash from operating activities | |||||||||||||||
Net income | $ | 4,428 | $ | 2,649 | $ | 36,282 | $ | 19,967 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||
Depreciation and amortization | 6,226 | 3,792 | 22,395 | 14,576 | |||||||||||
Amortization of operating lease right-of-use assets | 1,114 | — | 4,130 | — | |||||||||||
Stock-based compensation | 1,878 | 1,918 | 7,309 | 6,337 | |||||||||||
Deferred income taxes | (4,423 | ) | (31,455 | ) | — | ||||||||||
Other | (104 | ) | 59 | 32 | 224 | ||||||||||
Changes in operating assets and liabilities: | |||||||||||||||
Accounts receivable | 747 | 557 | (2,031 | ) | (908 | ) | |||||||||
Prepaid expenses and other current assets | 372 | (859 | ) | (4,031 | ) | (6,073 | ) | ||||||||
Other assets | 247 | (756 | ) | 1,376 | (4,447 | ) | |||||||||
Accounts payable | 241 | 137 | 511 | 614 | |||||||||||
Accrued employee expenses | 4,056 | 4,443 | 4,542 | 1,219 | |||||||||||
Accrued expenses | 69 | (116 | ) | 55 | 3,281 | ||||||||||
Deferred revenue | 154 | (342 | ) | 1,193 | (4,589 | ) | |||||||||
Operating lease liabilities | 224 | — | (2,662 | ) | — | ||||||||||
Other liabilities | 245 | 184 | 1,241 | 6,067 | |||||||||||
Net cash provided by operating activities | 15,474 | 11,666 | 38,887 | 36,268 | |||||||||||
Cash from investing activities | |||||||||||||||
Purchases of property, equipment and intangible assets | (3,999 | ) | (362 | ) | (8,084 | ) | (2,102 | ) | |||||||
Additions to capitalized software | (5,329 | ) | (3,307 | ) | (20,998 | ) | (12,304 | ) | |||||||
Purchases of investment securities | (14,508 | ) | (732 | ) | (25,198 | ) | (29,516 | ) | |||||||
Sales of investment securities | — | 20,199 | 2,750 | 20,900 | |||||||||||
Maturities of investment securities | 4,660 | 4,342 | 15,660 | 32,819 | |||||||||||
Acquisition, net of cash acquired | — | — | (54,004 | ) | (14,441 | ) | |||||||||
Net cash (used in) provided by investing activities | (19,146 | ) | 20,140 | (89,874 | ) | (4,644 | ) | ||||||||
Cash from financing activities | |||||||||||||||
Proceeds from stock option exercises | 294 | 322 | 553 | 1,035 | |||||||||||
Tax withholding for net share settlement | (614 | ) | (233 | ) | (6,155 | ) | (3,127 | ) | |||||||
Purchase of treasury stock | — | (21,562 | ) | — | (21,562 | ) | |||||||||
Proceeds from issuance of debt | 472 | 50,045 | 2,169 | 50,138 | |||||||||||
Principal payments on debt | (785 | ) | (45 | ) | (3,419 | ) | (138 | ) | |||||||
Payment of debt issuance costs | — | — | (420 | ) | — | ||||||||||
Net cash (used in) provided by financing activities | (633 | ) | 28,527 | (7,272 | ) | 26,346 | |||||||||
Net (decrease) increase in cash and cash equivalents and restricted cash | (4,305 | ) | 60,333 | (58,259 | ) | 57,970 | |||||||||
Cash, cash equivalents and restricted cash | |||||||||||||||
Beginning of period | 20,552 | 14,173 | 74,506 | 16,536 | |||||||||||
End of period | $ | 16,247 | $ | 74,506 | $ | 16,247 | $ | 74,506 |